86.20MMarket Cap-455P/E (TTM)
0.730High0.560Low547.94KVolume0.630Open0.621Pre Close351.88KTurnover0.62%Turnover RatioLossP/E (Static)153.93MShares5.25052wk High0.64P/B49.43MFloat Cap0.42052wk Low--Dividend TTM88.27MShs Float13.780Historical High--Div YieldTTM27.39%Amplitude0.393Historical Low0.642Avg Price1Lot Size
Renovaro Stock Forum
NEWS
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
RenovaroCube acquires 100% ownership of Cyclomics, solidifying their collaboration in cancer diagnostics.
The partnership with Oxford Nanopore and Nvidia enhances RenovaroCube's capabilities in early cancer detection and treatment monitoring.
RenovaroCube's open architecture AI platform combined with Cyclomics' 4th generation molecular technology enables accurate ...
The two companies have agreed to merge, with artificial intelligence medical technology firm GEDi becoming a wholly-owned subsidiary of Renovaro in a stock-for-stock acquisition.
No comment yet